From efficacy to effectiveness: child and adolescent eating disorder treatments in the real world (part 1)-treatment course and outcomes.
Adolescent
Anorexia nervosa
Bulimia nervosa
Child
Family based treatment
Family therapy for anorexia nervosa
Family therapy for bulimia nervosa
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
21 Feb 2022
21 Feb 2022
Historique:
received:
21
06
2021
accepted:
06
02
2022
entrez:
22
2
2022
pubmed:
23
2
2022
medline:
23
2
2022
Statut:
epublish
Résumé
Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatment pathways and outcomes for a specialist child and adolescent ED service across a five-year period. All consecutive referrals between August 2009 and January 2014 seen at the Maudsley Centre for Child and Adolescent Eating Disorders in London were included. Data are reported on for all young people who were offered treatment (N = 357). Most young people referred to the service were diagnosed with anorexia nervosa (AN)/Atypical AN (81%). Treatment for AN/Atypical AN (median 11 months) was predominantly ED focused family therapy (99%). Treatment for bulimia nervosa (BN)/Atypical BN (median seven months) was most commonly a combination of cognitive behavioural therapy and ED focused family therapy (87%). At discharge, 77% of the AN/Atypical AN group had a good or intermediate outcome and 59% of the BN/Atypical BN group reported no or fewer than weekly bulimic episodes. 27% of the AN/Atypical AN group had enhanced treatment with either day- and/or inpatient admissions (AIM group). The %mBMI at 3 months of treatment was strongest predictor of the need for treatment enhancement and more modestly EDE-Q and age at assessment. The AIM group at assessment had significantly lower weight, and higher ED and comorbid symptomatology and went on to have significantly longer treatment (16 vs. 10 months). At discharge, this group had significantly fewer good and more poor outcomes on the Morgan Russell criteria, but similar outcomes regarding ED and comorbid symptoms and quality of life. When analysis was adjusted for %mBMI at assessment, 1 and 3 months of treatment, differences in Morgan Russell outcomes and %mBMI were small and compatible with no difference in outcome by treatment group. This study shows that outcomes in routine clinical practice in a specialist community-based service compare well to those reported in research trials. The finding from research trials that early weight gain is associated with improved outcomes was also replicated in this study. Enhancing outpatient treatment with day treatment and/or inpatient care is associated with favourable outcome for most of the young people, although a longer duration of treatment is required. Most research reports on outcomes for clinical trials. This study aimed to evaluate outcomes in a ‘real world’ setting of a specialist child and adolescent eating disorder service (ED) in the UK. Case notes of 357 young people seen for treatment between August 2009 and January 2014 were reviewed. Demographic and treatment characteristics, physical health, ED symptoms, other psychological symptoms and quality of life data are reported. Most young people referred had anorexia nervosa or related difficulties and most received ED focused family therapy. At the end of treatment, the majority had a good or intermediate outcome, regardless of ED diagnosis. In a quarter of the young people, their treatment was enhanced with day or inpatient admissions. This group had more severe difficulties at assessment and had longer treatment but had similar outcomes at the end of treatment.
Sections du résumé
BACKGROUND
BACKGROUND
Findings from randomised control trials inform the development of evidence-based eating disorder (ED) practice guidelines internationally. Only recently are data beginning to emerge regarding how these treatments perform outside of research settings. This study aimed to evaluate treatment pathways and outcomes for a specialist child and adolescent ED service across a five-year period.
METHODS
METHODS
All consecutive referrals between August 2009 and January 2014 seen at the Maudsley Centre for Child and Adolescent Eating Disorders in London were included. Data are reported on for all young people who were offered treatment (N = 357).
RESULTS
RESULTS
Most young people referred to the service were diagnosed with anorexia nervosa (AN)/Atypical AN (81%). Treatment for AN/Atypical AN (median 11 months) was predominantly ED focused family therapy (99%). Treatment for bulimia nervosa (BN)/Atypical BN (median seven months) was most commonly a combination of cognitive behavioural therapy and ED focused family therapy (87%). At discharge, 77% of the AN/Atypical AN group had a good or intermediate outcome and 59% of the BN/Atypical BN group reported no or fewer than weekly bulimic episodes. 27% of the AN/Atypical AN group had enhanced treatment with either day- and/or inpatient admissions (AIM group). The %mBMI at 3 months of treatment was strongest predictor of the need for treatment enhancement and more modestly EDE-Q and age at assessment. The AIM group at assessment had significantly lower weight, and higher ED and comorbid symptomatology and went on to have significantly longer treatment (16 vs. 10 months). At discharge, this group had significantly fewer good and more poor outcomes on the Morgan Russell criteria, but similar outcomes regarding ED and comorbid symptoms and quality of life. When analysis was adjusted for %mBMI at assessment, 1 and 3 months of treatment, differences in Morgan Russell outcomes and %mBMI were small and compatible with no difference in outcome by treatment group.
CONCLUSIONS
CONCLUSIONS
This study shows that outcomes in routine clinical practice in a specialist community-based service compare well to those reported in research trials. The finding from research trials that early weight gain is associated with improved outcomes was also replicated in this study. Enhancing outpatient treatment with day treatment and/or inpatient care is associated with favourable outcome for most of the young people, although a longer duration of treatment is required.
Most research reports on outcomes for clinical trials. This study aimed to evaluate outcomes in a ‘real world’ setting of a specialist child and adolescent eating disorder service (ED) in the UK. Case notes of 357 young people seen for treatment between August 2009 and January 2014 were reviewed. Demographic and treatment characteristics, physical health, ED symptoms, other psychological symptoms and quality of life data are reported. Most young people referred had anorexia nervosa or related difficulties and most received ED focused family therapy. At the end of treatment, the majority had a good or intermediate outcome, regardless of ED diagnosis. In a quarter of the young people, their treatment was enhanced with day or inpatient admissions. This group had more severe difficulties at assessment and had longer treatment but had similar outcomes at the end of treatment.
Autres résumés
Type: plain-language-summary
(eng)
Most research reports on outcomes for clinical trials. This study aimed to evaluate outcomes in a ‘real world’ setting of a specialist child and adolescent eating disorder service (ED) in the UK. Case notes of 357 young people seen for treatment between August 2009 and January 2014 were reviewed. Demographic and treatment characteristics, physical health, ED symptoms, other psychological symptoms and quality of life data are reported. Most young people referred had anorexia nervosa or related difficulties and most received ED focused family therapy. At the end of treatment, the majority had a good or intermediate outcome, regardless of ED diagnosis. In a quarter of the young people, their treatment was enhanced with day or inpatient admissions. This group had more severe difficulties at assessment and had longer treatment but had similar outcomes at the end of treatment.
Identifiants
pubmed: 35189967
doi: 10.1186/s40337-022-00553-6
pii: 10.1186/s40337-022-00553-6
pmc: PMC8862310
doi:
Types de publication
Journal Article
Langues
eng
Pagination
27Informations de copyright
© 2022. The Author(s).
Références
Int J Methods Psychiatr Res. 2018 Sep;27(3):e1610
pubmed: 29465165
Psychol Bull. 2003 Sep;129(5):747-69
pubmed: 12956542
Front Psychiatry. 2020 Jan 22;10:1001
pubmed: 32038332
Am J Psychiatry. 2004 Dec;161(12):2215-21
pubmed: 15569892
Ups J Med Sci. 2016;121(1):50-9
pubmed: 26915921
Arch Gen Psychiatry. 2010 Oct;67(10):1025-32
pubmed: 20921118
Curr Opin Psychiatry. 2017 Nov;30(6):423-437
pubmed: 28777107
Int J Eat Disord. 2018 Nov;51(11):1261-1269
pubmed: 30265750
J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):726-37
pubmed: 3058677
J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):683-92
pubmed: 27453082
Child Adolesc Psychiatry Ment Health. 2020 May 2;14:16
pubmed: 32391079
Eat Disord. 2018 May-Jun;26(3):270-277
pubmed: 29087249
BMC Psychiatry. 2017 Sep 15;17(1):333
pubmed: 28915806
Curr Psychiatry Rep. 2018 Aug 9;20(9):79
pubmed: 30094740
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Int J Eat Disord. 2021 Jan;54(1):107-116
pubmed: 33290613
J Child Adolesc Psychopharmacol. 2011 Jun;21(3):213-20
pubmed: 21510781
Int J Eat Disord. 2007 Dec;40(8):751-3
pubmed: 17683094
J Adolesc Health. 2014 Dec;55(6):750-6
pubmed: 25200345
Aust N Z J Psychiatry. 2014 Nov;48(11):977-1008
pubmed: 25351912
J Adolesc. 2003 Feb;26(1):137-42
pubmed: 12550826
J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):886-94.e2
pubmed: 26506579
Eat Disord. 2019 Jul-Aug;27(4):400-417
pubmed: 30358497
J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6
pubmed: 10517055
Behav Res Ther. 2015 Feb;65:36-41
pubmed: 25557396
Int J Eat Disord. 2015 Nov;48(7):946-71
pubmed: 26171853
Eur Eat Disord Rev. 2014 Jan;22(1):53-8
pubmed: 23861093
J Eat Disord. 2022 Feb 5;10(1):14
pubmed: 35123587
J Eat Disord. 2017 Mar 2;5:4
pubmed: 28265410
Int J Eat Disord. 2014 Mar;47(2):124-9
pubmed: 24190844
Int J Eat Disord. 2020 Jan;53(1):3-19
pubmed: 31506978
Psychiatr Danub. 2013 Sep;25 Suppl 2:S295-9
pubmed: 23995197
BMC Psychiatry. 2016 Nov 24;16(1):422
pubmed: 27881106
Arch Gen Psychiatry. 2011 Jul;68(7):714-23
pubmed: 21383252
Int J Eat Disord. 2012 Apr;45(3):428-38
pubmed: 21744375
JAMA Psychiatry. 2014 Nov;71(11):1279-86
pubmed: 25250660
Lancet. 2014 Apr 5;383(9924):1222-9
pubmed: 24439238
Soc Psychiatry Psychiatr Epidemiol. 2016 Mar;51(3):369-81
pubmed: 26631229
Health Qual Life Outcomes. 2007 Apr 30;5:23
pubmed: 17470290
Am J Psychiatry. 2007 Apr;164(4):591-8
pubmed: 17403972
BMJ Open. 2019 Sep 20;9(9):e031707
pubmed: 31542765
Int J Eat Disord. 2016 Sep;49(9):891-4
pubmed: 27062400
Arch Gen Psychiatry. 1987 Dec;44(12):1047-56
pubmed: 3318754
J Child Psychol Psychiatry. 1995 Feb;36(2):327-34
pubmed: 7759594
J Eat Disord. 2020 Nov 13;8(1):68
pubmed: 33292696
Int J Eat Disord. 2016 Nov;49(11):1023-1026
pubmed: 27270494
Arch Gen Psychiatry. 2007 Sep;64(9):1049-56
pubmed: 17768270